Mesothelioma Patients Benefit from Receiving Universal Germline Testing
This new data indicated a necessity for clinical strategies made to handle unintentional pathogenic or likely pathogenic germline variants seen in tumor-only next-generation sequencing.
Linkedin Michaelw Drazer Michaelw Drazer Nat Genet Laboratory Of University Chicago Genetic Services Department Of Medicine Section Hematology Oncology University Of Chicago Medicine
Source: hcplive.com